Highlights Haisco Pharmaceutical Group Co., Ltd.

Equities

002653

CNE100001BC7

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 01/07/2024 am IST			5-day change	1st Jan Change
31.26 ^CNY	+1.82%		-5.44%	+35.03%

13/06	Haisco Pharmaceutical Gets Nod to Trial Tumor Drug; Shares Up 3%	MT
16/05	Chinese Drug Regulator Accepts Haisco Pharma's Application for Pulmonary Disease Drug	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Haisco Pharmaceutical Gets Nod to Trial Tumor Drug; Shares Up 3%	13/06	MT
Chinese Drug Regulator Accepts Haisco Pharma's Application for Pulmonary Disease Drug	16/05	MT
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	19/04	CI
Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules	18/04	MT
Haisco Pharma Gets Nod to Trial Asthma Drug	10/04	MT
Haisco Pharma Gets Nod to Trial HSK16149 Capsule as Central Neuropathic Pain Drug	01/04	MT
Haisco Pharma's Unit Gets Nod to Trial Drug for Hemolytic Diseases	25/03	MT
Haisco Pharma's Unit Gets Nod to Trial Tumor Drug Candidate	28/02	MT
Haisco Pharma to Set Up New Subsidiary in China’s Tibet Region	18/01	MT
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	16/23/16	CI
Haisco Pharmaceutical's Unit Gets Greenlight to Trial Diabetes Drug	14/23/14	MT
Haisco Pharma's Rupatadine Fumarate Tablets Passes Regulator's Evaluation	02/23/02	MT
Haisco Pharma Unit Gets Certification for Formula Food	27/23/27	MT
Haisco Pharma Gets Nod for HSK31679 Tablet Trial	26/23/26	MT
Haisco Pharma Unit Registers Nutritional Formula Food	17/23/17	MT
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/23/17	CI
Haisco Pharma Unit Gets Certificate for Two Food Supplements	17/23/17	MT
Haisco Pharmaceutical Gets Nod for China Clinical Trial of Lung Cancer Drug; Shares Jump 3%	16/23/16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Haisco Pharmaceutical Group Co., Ltd.

Equities

002653

CNE100001BC7

Highlights

Filters